Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Langenbeck's Archives of Surgery
Published in: Langenbeck's Archives of Surgery 6/2021

01-09-2021 | Computed Tomography | Systematic Reviews and Meta-analyses

Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis

Authors: Hailun Xie, Lishuang Wei, Mingxiang Liu, Guanghui Yuan, Shuangyi Tang, Jialiang Gan

Published in: Langenbeck's Archives of Surgery | Issue 6/2021

Login to get access

Abstract

Background

The relationship between computed tomography (CT)-assessed sarcopenia and colorectal cancer (CRC) prognosis varies in different studies. This systematic review aimed to examine the impact of preoperative CT-assessed sarcopenia on complications and long-term survival in CRC patients.

Methods

The PubMed, Web of Science, Cochrane Library, and Embase databases were searched for relevant literature up to September 10, 2020. Data and characteristics for each study were extracted. Long-term outcomes were assessed using a comprehensive HR with a 95% CI. Complications were assessed using a comprehensive OR with 95% CI. The heterogeneity and publication bias were also investigated, and subgroup and sensitivity analyses were performed.

Results

A total of 19 studies comprising 15,889 patients were included. The comprehensive results demonstrated that sarcopenia is significantly associated with overall survival of CRC patients (HR = 1.40, 95% CI = 1.25–1.58, p < 0.001). Patients with sarcopenia have a higher risk of complications compared to those without sarcopenia. In addition, sarcopenia is strongly associated with poor cancer-specific survival (HR = 1.49, 95% CI = 1.32–1.68, p < 0.001) and disease-free survival (HR = 1.59, 95% CI = 1.32–1.92, p < 0.001) in CRC patients. There is no significant relationship between sarcopenia and recurrence-free survival (HR = 1.32, 95% CI = 0.92–1.89, p = 0.126).

Conclusions

Preoperative CT-assessed sarcopenia can be employed as an effective predictor of complications and long-term prognosis in CRC patients. Standardization of CT-assessed sarcopenia requires comprehensive consideration of race, muscle mass index, body mass index, and gender.
Appendix
Available only for authorised users
Literature
1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424PubMedCrossRef
2.
3.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289PubMedCrossRef
4.
Yang Z, Zhou X, Ma B, Xing Y (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg 22(11):1890–1902PubMedCrossRef
5.
Bundred J, Kamarajah SK, Roberts KJ (2019) Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB (Oxford) 21(12):1603–1612CrossRef
6.
Yang M, Shen Y, Tan L, Li W (2019) Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest 156(1):101–111PubMedCrossRef
7.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423PubMedPubMedCentralCrossRef
8.
Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR (2008) Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr 87(5):1562s-s1566PubMedCrossRef
9.
Sayer AA, Dennison EM, Syddall HE, Jameson K, Martin HJ, Cooper C (2008) The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J Gerontol A Biol Sci Med Sci 63(8):835–840PubMedCrossRef
10.
Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319PubMedCrossRef
11.
Dolan RD, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC (2019) The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle 10(1):111–122PubMedCrossRef
12.
Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S et al (2020) Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat 52(3):957–972PubMedPubMedCentralCrossRef
13.
Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):8153PubMedPubMedCentralCrossRef
14.
van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, Dekker JWT, Zimmerman DDE et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360PubMedCrossRef
15.
Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X et al (2018) Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis 33(10):1419–1427PubMedCrossRef
16.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71PubMedPubMedCentralCrossRef
17.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16PubMedPubMedCentralCrossRef
18.
Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF et al (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis 17(11):O256–O264PubMedCrossRef
19.
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22(8):2663–2668PubMedCrossRef
20.
Malietzis G, Currie A, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R et al (2016) Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 103(5):572–580PubMedCrossRef
21.
Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E et al (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 26(7):1008–1015PubMedPubMedCentralCrossRef
22.
Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319PubMedCrossRef
23.
Chen W-Z, Chen X-D, Ma L-L, Zhang F-M, Lin J, Zhuang C-L et al (2018) Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci 63(6):1620–1630PubMedCrossRef
24.
Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K et al (2018) Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 48(2):151–157PubMedCrossRef
25.
Sueda T, Takahasi H, Nishimura J, Hata T, Matsuda C, Mizushima T et al (2018) Impact of low muscularity and myosteatosis on long-term outcome after curative colorectal cancer surgery: a propensity score–matched analysis. Dis Colon Rectum 61(3):364–374PubMedCrossRef
26.
van Vugt JL, van den Braak RRC, Lalmahomed ZS, Vrijland WW, Dekker JW, Zimmerman DD et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360PubMedCrossRef
27.
Hopkins JJ, Reif RL, Bigam DL, Baracos VE, Eurich DT, Sawyer MB (2019) The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis Colon Rectum 62(5):549–560PubMedCrossRef
28.
Yang J, Zhang T, Feng D, Dai X, Lv T, Wang X et al (2019) A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer. Colorectal Dis 21(5):538–547PubMedCrossRef
29.
30.
Chen W, Huang Y, Xu L, Shi M, Chen X, Ye G et al (2020) Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: a prospective study. Neoplasma 67(4):922–932PubMedCrossRef
31.
Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO et al (2020) Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treatment 52(2):563CrossRef
32.
Lee CS, Won DD, Oh SN, Lee YS, Lee IK, Kim IH, Choi MH, Oh ST (2020) Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World J Surg Oncol 18(1):230. https://​doi.​org/​10.​1186/​s12957-020-02006-3
33.
Shirdel M, Andersson F, Myte R, Axelsson J, Rutegård M, Blomqvist L, Riklund K, van Guelpen B, Palmqvist R, Gylling B (2020) Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease. Acta Oncol 59(7):799–808. https://​doi.​org/​10.​1080/​0284186X.​2020.​1744716
34.
35.
Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):1–11
36.
Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574PubMedCrossRef
37.
38.
39.
40.
Simonsen C, Kristensen TS, Sundberg A, Wielsøe S, Christensen J, Hansen CP et al (2021) Assessment of sarcopenia in patients with upper gastrointestinal tumors: prevalence and agreement between computed tomography and dual-energy x-ray absorptiometry. Clin Nutr 40(5):2809–2816PubMedCrossRef
41.
Goodpaster BH, Thaete FL, Kelley DE (2000) Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci 904(1):18–24PubMedCrossRef
42.
Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewé KW, Hoofwijk AG et al (2015) Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 261(2):345–352PubMedCrossRef
43.
Wen M-J, Hsieh C-H, Wu C-Z, Hsiao F-C, Hsia T-L, Hung Y-J et al (2013) The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: a pilot study. Obes Res Clin Pract 7(3):e206–e210PubMedCrossRef
44.
Van Vledder M, Levolger S, Ayez N, Verhoef C, Tran T, Ijzermans J (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99(4):550–557PubMedCrossRef
45.
Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PloS one. 7(8):e41883PubMedPubMedCentralCrossRef
46.
Alemán MR, Santolaria F, Batista N, Marıa J, González-Reimers E, Milena A et al (2002) Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 19(1):21–6PubMedCrossRef
47.
Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM (2013) Effect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review. Crit Rev Oncol Hematol 88(3):573–593PubMedCrossRef
48.
Strasser B, Steindorf K, Wiskemann J, Ulrich CM (2013) Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 45(11):2080–2090PubMedCrossRef
49.
Dallmann R, Weyermann P, Anklin C, Boroff M, Bray-French K, Cardel B et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. J Cachexia Sarcopenia Muscle 2(3):163–174PubMedPubMedCentralCrossRef
50.
Berardi E, Annibali D, Cassano M, Crippa S, Sampaolesi M (2014) Molecular and cell-based therapies for muscle degenerations: a road under construction. Front Physiol 5:119PubMedPubMedCentralCrossRef
51.
Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd (2005) Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60(2):213–216PubMedCrossRef
Metadata
Title
Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis
Authors
Hailun Xie
Lishuang Wei
Mingxiang Liu
Guanghui Yuan
Shuangyi Tang
Jialiang Gan
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 6/2021
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-021-02274-x

Other articles of this Issue 6/2021

Langenbeck's Archives of Surgery 6/2021 Go to the issue

How-I-Do-It articles

Hepatic artery resection without reconstruction in pancreatoduodenectomy

Original Article

Perineural invasion and number of retrieved lymph nodes are prognostic factors for T2N0 colon cancer

Systematic Reviews and Meta-analyses

EUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis

Original Article

Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer

For Debate

Objective method for selective reconstruction of multiple graft arteries to potentially reduce biliary complications

Original Article

Anatomical Basis for Selective Multiple Arterial Reconstructions in Living Donor Liver Transplantation